1 / 55

Arterial Fibrodysplasia

Arterial Fibrodysplasia. Encompasses a heterogenous group of arterial dysplastic lesions affecting small and medium-sized arteries Unknown etiology Described in every artery Most common: Renal. Arterial Fibrodysplasia.

talor
Download Presentation

Arterial Fibrodysplasia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Arterial Fibrodysplasia Encompasses a heterogenous group of arterial dysplastic lesions affecting small and medium-sized arteries Unknown etiology Described in every artery Most common: Renal

  2. Arterial Fibrodysplasia • Dysplastic process usually results in stenosis, but can also cause aneurysms • Occlusive renal artery lesions: most common cause of surgically correctable HTN • Renovascular HTN: • Goldblatt H 1934: Established link between renal ischemia and hypertension using constricting clamp • Atherosclerotic disease most common (>90%) • Fibrodysplastic disease second (0.5% of general population)

  3. Arterial Fibrodysplasia • Renal artery fibrodysplasia: • Pathology • Clinical manifestations • Indications for therapeutic intervention • Drug Therapy • PTRA • Role of surgery

  4. Pathology • Arterial dysplasia: categorized according to layer of wall involved • 1) intimal fibroplasia • 2) medial hyperplasia • 3) medial fibroplasia • 4) perimedial dysplasia • 5) developmental stenoses Distinct pathologic processes Continuum of same disease

  5. Pathology • Intimal fibroplasia: • 5% of all fibrodysplastic renal artery lesions • Affects children and adults equally • Occurs as long tubular stenosis in children, smooth focal stenoses in adults • Progression slower than medial fibroplasia

  6. Pathology • Medial hyperplasia: • 1% of fibrodysplastic renal artery lesions • Angiographically similar to intimal hyperplasia • Most often in women (30 to 50 y.o.) • Usually as isolated lesion in midportion of main renal artery

  7. Pathology • Medial fibroplasia: • 85% of all dysplastic renal artery lesions • White women (30-40 y.o.) • Bilateral in 55%, when unilateral 80% are on the right • Angiographic appearance: classic “string of beads”

  8. Pathology • Perimedial dysplasia: • Accumulation of elastic tissue at media-adventitia junction • 10% of arterial dysplastic lesions • Younger women • Either focal stenoses or multiple stenoses of main renal artery

  9. Etiology • Unknown • 3 factors: • Hormonal influences • Arterial wall ischemia • Mechanical stresses

  10. Pathology • Higher incidence of arterial dysplasia in women of reproductive years: role of estrogen • ?Ischemia of artery wall secondary to injury of vasa vasorum of vessels • Repeated stretching of vessels may trigger a fibroproliferative response (right renal artery is longer and may be subject to greater axial stretch)

  11. Clinical Manifestations Prevalence of renovascular HTN in patients with HTN is low (2-5%) HTN caused by arterial fibrodysplasia is even less common First lesson in dx renovascular HTN: recognizing clinical cues

  12. 160 180

  13. Pathology • Stanley JC et al. • U Mich series • 88% with renal arterial fibrodysplasia causing renovascular HTN showed atypical media-perimedial dysplasia • 33 boys (mean age 9.5), 24 girls (12) • Average duration of HTN(14.2 months) • Mean BP before drug therapy: 181/117 • Mean BP after drug therapy: 158/104

  14. Pathology • Stanley JC et al. • U Mich series • 133 women, 11 men • Mean age: M 31; F 39 • Average duration of HTN: 43 months • BP before therapy: 206/122 • BP after durg treatment: 184/111

  15. Indications for Tx • Depend largely on age at presentation • Pediatrics: incidence of essential HTN is negligible • Most instances of HTN in this patient population represent a renovascular etiology • Mod to severe BP elevations in this patient population: detailed diagnostic studies warranted in search of correctable cause of HTN

  16. Indications for Tx • Indications for intervention in adults: • Presence of moderate to severe HTN • HD significant renal artery stenosis • Evidence of the functional importance of the stenosis

  17. Indications for Tx • Dramatic improvement in drug therapy for HTN has raised the threshold for intervention in renovascular HTN • Has led to older age at presentation and duration of HTN • Functional significance of fibrodysplasia is more challenging since these older patients have higher incidence of essential HTN, atherosclerotic disease

  18. Screening Tests • Most commonly used screening studies: • Renal duplex u/s • MRA • Radionuclide scan (Renal scintigraphic captopril test) • Captopril: efferent arteriolar vasodilation reduces driving pressure across glomerulus, reducing GFR • Glomerular radionuclide tracer uptake by kidney is markedly decreased • CTA

  19. Indications for Tx • Vasbinder GB et al. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular HTN: a meta-analysis. Ann Intern Med 2001; 135:401-11 • Established the superiority of CTA and MRA over other non-invasive screening tests for renovascular HTN • 98% sensitive, 94% specific

  20. Indications for Tx • Once patient has been identified on the basis of clinical clues and/or use of screening studies • Angiography is most useful test for assessing hemodynamic and functional significance of renal artery dysplastic occlusive disease • Gold standard

  21. Indications for Tx • Angiographic features to determine hemodynamic significance of dsyplastic renal artery stenosis • Demonstration of collateral vessels (usually develops when pressure gradient across stenosis approaches 10 mmHg) • 10 mm Hg is generally accepted association with increase release of renin from JXA

  22. Indications for Tx • Renin assays: • Have been important in determining functional significance of equivocal renal artery stenoses • Most useful in patients with medically controlled HTN and older patients with arterial fibrodysplasia and extrarenal atherosclerosis • Younger patients with poorly controlled HTN or threatened ischemic nephropathy, dx may be made via renin profiling with the renal systemic renin index (RSRI)

  23. Indications for Tx • Renal systemic renin index (RSRI): alternative calculation of each kidney’s renin secretory activity • Subtract systemic renin activity from renal vein renin activity and dividing remainder by the systemic renin activity • Renin hypersecretion: RSRI > 0.38 • Suppression of renin secretion by a kidney defined as RSRI < 0.24

  24. Indications for Tx • Renal vein renin ratio (RVRR): compares renin activity in venous effluent from ischemic and contralateral kidneys has not been a highly predictive test • Not reliable largely due to bilateral disease • Considered abnormal when > 1.48

  25. Drug Therapy • Renin-angiotensin-mediated vasoconstriction is primary mechanism of hypertension in patients with unilateral renal artery stenosis and normal contralateral kidney. • In bilateral renal artery stenosis, renin-angiotensin-aldosterone mediated sodium retention and hypervolemia are the dominant pathophysiologic mechanisms for HTN

  26. Drug Therapy • B-blocker often first drug given (Inhibition of renin secretion by B-blockade) • In bilateral renal artery stenoses, the addition of diuretic may be used to treat hypervolemic state in these patients • Thiazide, Lasix • ACE inhibitor, angiotensin II antagonist (good for LVH, heart failure, diabetic nephropathy) • Ca channel blockers • Clonidine • Hydralazine

  27. Drug Therapy • Undisputed: optimizing medical therapy reduces cardiovascular morbidity • Unclear: its role in delaying the progression of nephropathy

  28. Drug Therapy • At least three randomized controlled trials comparing medical therapy with and without angioplasty • Van Jaarsveld BC et al. N Engl J Med 2000 • Plouin PF et al. Hypertension 1998 • Webster J et al. Scottish and Newcastle Renal Artery Stenosis Collaborative Group J Hum Hypertension 1988 • No difference in BP control or preservation of renal function • However, in largest of these studies (Plouin et al), half crossed over to receive angioplasty for poorly controlled BP within 3 months

  29. PTRA • Percutaneous transluminal renal angioplasty (PTRA) has become the dominant mode of tx of renal arterial dysplasia at most institutions • Angioplasty deemed technically successful when preexisting pressure gradients across stenosis are abolished • Anatomic documentation of an adequate dilatation

  30. PTRA • The majority of fibrodysplastic lesions may be treated with PTRA alone • Stent placement is reserved for rescue in failed PTRA or renal artery dissection • Mechanism of balloon angioplasty: • Artery wall stretched, separating intima from underlying structures, splitting media, and stretching adeventitia beyond elastic recoil • Dilated artery undergoes fibroproliferative reparative process forming neointima

  31. PTRA • Approximately 85% of adult patients with renal artery fibrodysplasia and renovascular HTN benefit from PTRA • Best results with patients with unilateral medial fibroplasia

  32. PTRA • Mean overall complication rate after renal angioplasty: 11% • Complications: dissection, perforation • Contraindicated in associated macroaneurysms, extensive branch vessel disease, or complex dissections • Failures correlate with longer duration of HTN and older age of patients at time of presentation for tx • Trends in outcome after PTRA parallel those in surgical management

  33. PTRA • Results of PTRA for renal artery fibrodysplasia in pediatric population less encouraging • Renal artery stenosis associated with neurofibromatosis or aortic anomalies are likely to fail PTRA • Watson et al. J Pediatr • 60% of unsuccessful angioplasties resulted in nephrectomies

  34. Surgical Therapy • Key: Adequate exposure • Transverse incision (midclavicular to midaxillary on side of renal artery reconstruction) • Midline incision • Right-sided reconstruction: • Expose renal artery,vein, IVC, aorta by mobilizing right colon and hepatic flexure. Kocher maneuver

  35. Surgical Therapy

  36. Surgical Therapy • For left-sided reconstructions: • Reflection of viscera (mobilization of left colon) • Exposure of left renal artery usually requires mobilization of the renal vein with ligation and transection of gonadal branch inferiorly and adrenal venous branches superiorly

  37. Surgical Therapy • Right sided aortorenal grafts: retrocaval position usually best

  38. Surgical Therapy • Left sided: grafts usually positioned beneath left renal vein • Other sites for anastomosis: hepatic, splenic, common iliacs • For graft-renal artery anastomosis, end-to-end anastomosis is preferred to end-to-side (spatulation of graft posteriorly and renal artery anteriorly) • In pediatric population, interrupt sutures to allow for anastomotic growth

  39. Surgical Therapy • Autologous vein grafts preferred • Autologous hypogastric artery grafts are favored bypass procedures in children • Dacron, PTFE grafts

  40. Surgical Therapy • For proximal segmental disease pattern, there are three methods of repair: • Separate implantations of renal arteries into single conduit • In situ anastomosis of involved renal arteries in side-to-side manner to form common orifice

  41. Surgical Therapy • Remimplantation of an affected artery beyond its diseased segment into adjacent normal artery (end-to-side) • Ex vivo repairs: • Require mobilization of entire kidney including accompanying vasculature and ureter to the pelvis • Renal artery vein transected • Tourniquet around intact ureter to prevent collateral blood flow

  42. Surgical Therapy • Cold LR to flush kidney of venous effluent • Kidney connected to perfusion mannifold • Hypothermic perfusion begun • Dissection of renal artery to level of visible/palpable disease • Iliac artery arterial autograft flushed • Sequential branch anastomoses in end-to-end fashion over metal dilator to prevent narrowing

  43. Surgical Therapy • Perfusion cannulas removed, kidney repositioned in retroperitoneum • Proximal aortic anastomosis, renal vein anastomosis completed • In situ repairs: • Appropriate when patient has 2 kidneys requiring primary repair limited to first bifurcation

  44. Surgical Therapy • Ex vivo repairs: • Reoperation for failed prior renal arterial repairs • Multiple branch artery lesions in single kidney • Extension of branch vessel disease into renal hilum • Certain branch artery stenoses in children • Traumatic injuries involving the renal hilum • Stenoses involving multiple renal arteries

  45. Surgical Therapy • Alternative reconstructions: • Splenorenal bypass (left-sided); must document normal celiac artery • Should not be done in pediatric patients • Complex reconstructions: • Operative tx of fibrodysplastic renovascular HTN in face of aortic hypoplasia or corarctation • Thorocoabdominal bypasses and local aortoplasties with concomitant renal artery construction • Operative mortality 8%, 90% of survivors benefit

  46. Surgical Therapy • Incidence of early postoperative aortorenal vein graft thrombosis: 2-7% • Occurs less often with arterial autografts • More common in small-diameter arteries and branch vessel reconstructions • Study of choice to r/o early postoperative graft occlusion: arteriography

  47. Surgical Therapy • Late vein graft stenoses: 8% • Intimal hyperplasia • Clamp injury • Traumatic dilator advancement • Marked aneurysmal change in aortorenal grafts: • 2% in adults • 20% of vein grafts in pediatric population

  48. Surgical Therapy • “Beneficial outcomes after operative intervention for renovascular HTN are directly proportional to the accurate identification of appropriate surgical candidates and performance of adequate reconstructive procedure” • Cooperative Study of Renovascular HTN: • Less than optimal results: ?errors in patient selection and early technical failures • 577 surgeries in 520 patients with all forms of renovascular HTN • 51% cure, 15% improvement, 34% failure • Renal artery fibrodysplasia more responsive than for atherosclerotic disease

More Related